Boston Scientific loses stent verdict

Interventional device manufacturer Boston Scientific of Natick, MA, has lost a jury verdict in a patent infringement case with rival Johnson & Johnson of New Brunswick, NJ, over stent technology.

A jury ruled that a Johnson & Johnson patent for its Palmaz stent was valid, and that Boston Scientific's NIR stent infringed on the patent. The NIR stent was designed and manufactured by Medinol, and was formerly sold by Boston Scientific. The company no longer sells the stent.

Monetary damages will be determined at a later hearing, according to the company, which said it would appeal the decision. The ruling does not affect Boston Scientific's flagship Taxus family of stents, the company said.

By staff writers
March 25, 2005

Related Reading

Boston Scientific continues robust growth, February 1, 2005

Court issues judgment in stent patent dispute, January 6, 2005

Boston Scientific provides tsunami aid, December 31, 2004

Boston Scientific to acquire AST, December 17, 2004

Boston Scientific aligns with REVA, November 16, 2004

Copyright © 2005

Page 1 of 180
Next Page